Research and Markets: Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/e2dd9a/contraceptives_mar) has announced the addition of the "Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future" report to their offering.

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts. The report provides an in-depth analysis of the most commonly used contraceptives, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. It also examines treatment usage patterns of oral, topical and injectable contraceptives. In addition, the report also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape. Finally, the report also includes analysis on mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research's team of industry experts.

High Growth Rate and Increasing Awareness Have Made Contraceptive Market Attractive

Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002 - 2017 The global hormonal contraceptive market is a fast growing market, with oral contraceptives considered to be the most common method of avoiding unplanned pregnancies. In 2010, the global contraceptives market was valued at $15.5 billion and is forecast to grow to $19.2 billion by 2017, which represents a growth rate of 3.1% from 2010 - 2017. According to a report by the Guttmacher Institute, the number of women who require publicly funded contraceptives increased by one million from 2001 - 2004. An increase in the number of women who require publicly funded contraception indicates an increasing awareness among women of contraceptive methods. The use of contraceptive devices such as condoms, intrauterine devices and vaginal rings will increase market value. Increasing awareness will accelerate growth in the contraceptive market by 2017. As a result, market growth will continue and this will attract the attention of pharmaceutical companies. Strong Pipeline and the Entry of New Companies Will Intensify Competition

Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011 The contraceptives market has a strong pipeline base which supports growth in the market and attracts many pharmaceutical and biotechnological companies. Major pharmaceutical companies such as Teva, Watson, Bayer and Merck have active contraceptive pipelines. One of the main activities in the market at present is the development of generic versions of off-patent drugs. The entry of generic versions will strengthen the oral contraceptive market and lead to further growth in the hormonal contraceptives market. Of all pipeline molecules, 72% are in Phase II and Phase III of clinical trials. In the forecast period, the CSD500, a condom manufactured by Futura Medical and licensed to Reckitt and Benckiser, will strengthen the condom market. Additionally, the entry of new companies is set to intensify competition in the condom market. Also, the presence of a highly active pipeline in this market indicates strong competition in the future.

1 Tables & Figures

2 Contraceptives Market to 2017- Introduction

3 Contraceptives Market to 2017 - Market Overview

4 Contraceptives Market to 2017- Geographical Landscape

5 Contraceptives Market to 2017 - Therapeutic landscape

6 Contraceptives Market to 2017 - Devices landscape

7 Contraceptives Market to 2017 - Pipeline Analysis

8 Contraceptives Market to 2017 - Competitive Landscape

9 Contraceptives Market to 2017 - M&A Landscape

10 Contraceptives Market to 2017 - Appendix

Companies Mentioned:

  • Yaz/ Yasmin
  • Mirena
  • Nuvaring
  • Bayer
  • Johnson & Johnson
  • Church & Dwight
  • Merck
  • Reckitt & Benckiser

For more information visit http://www.researchandmarkets.com/research/e2dd9a/contraceptives_mar

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716